Antibody-drug-conjugate (ADC) analysis Featured Content
-
Antibody-Drug Conjugate (ADC) Analysis With An Analyzer System
6/25/2026
High-resolution CE-SDS analysis reveals detailed ADC size and heterogeneity profiles, enabling accurate comparison of conjugation strategies. See how teams can strengthen quality control across workflows.
-
Measuring ADC Positional Isomers Using Nonreduced CE-SDS And HIC
6/24/2026
Combining HIC and nonreduced CE-SDS data enables estimation of ADC positional isomers. See how a system-of-equations approach offers practical structural insight without adding specialized assays.
-
Characterization Of Antibody-Drug Conjugate Critical Quality Attributes
6/23/2026
ADCs and next-generation conjugates demand precise control of DAR and advanced analytical strategies. Learn how evolving techniques support accurate characterization and ensure consistent performance.
-
Characterization Of Antibody-Drug Conjugate Critical Quality Attributes
6/18/2026
Accurate assessment of DAR and aggregation is key to ADC quality. Multi-temperature UV-Vis analysis enables efficient measurements with simplified workflows, helping teams make confident decisions.
-
Analysis Of ADCs Using Hydrophobic Interaction Chromatography
6/18/2026
Accurate DAR analysis in HIC requires systems that withstand corrosive salt conditions. Bioinert flow paths and baseline correction tools improve reproducibility, enabling confident characterization of ADCs.
-
Characterization Of Antibody‑Drug Conjugates Using 2D-LC And Native MS
6/18/2026
Accurate DAR measurement is critical for ADC performance, yet traditional methods can compromise integrity. See how an MS workflow combining HIC, heart-cutting, and SEC enables more reliability.
-
Analysis Of Free Drug Content In Antibody-Drug Conjugate
6/18/2026
Free drug content can compromise ADC safety and performance if not carefully measured. A multidimensional LC/Q-TOF workflow pairs SEC and reversed-phase separation to enable sensitive detection.
-
Protein And Payload Stability Of Brentuximab Vedotin In Monkey Plasma
6/18/2026
Examine an approach that enables precise measurement of protein and payload stability for antibody–drug conjugates in plasma, helping researchers better understand molecular behavior over time.
-
Intact- And Peptide-Level Characterization Of T-DM1 In Vitro
6/18/2026
A sensitive workflow that combines affinity capture and high-resolution mass spectrometry reveals how antibody-drug conjugates evolve under physiological conditions, offering deeper insight into their stability.
-
Identification Of Conjugation Sites In An Antibody Drug Conjugate
6/18/2026
A streamlined workflow enables confident mapping of lysine-linked conjugation sites in ADCs. See how integrated automation and high-resolution analysis simplify complex characterization challenges.